Abstract:Cl(-) /HCO (3)(-) exchanger and Na(+) /H(+) exchanger 3 are the main transporters responsible for NaCl reabsorption in kidney proximal tubules (PT). It is well accepted that membrane exchangers can be regulated by reactive oxygen species (ROS). In the kidney, ROS are known to contribute to decreases in Na(+) excretion and consequently increase blood pressure. The present study investigated mechanisms by which H(2) O(2) -induced stimulation of Cl(-) /HCO (3)(-) exchanger activity is enhanced in proximal tubular… Show more
“…In fact, in immortalized SHR PTE cells, H 2 O 2 has been shown to stimulate Cl Ϫ /HCO 3 Ϫ exchanger activity via modification of thiol groups of intracellular and/or transmembrane proteins. The oxidized conformation of the exchanger enhanced the affinity for HCO 3 Ϫ in immortalized SHR PTE cells but not in WKY PTE cells (93). Cysteine residues of proteins are especially susceptible to oxidative stress and, given the important role that disulfides play in protein structure and stability, alterations of reactive cysteine thiol groups may change protein function and activity.…”
Several clinical and animal studies suggest that "blood pressure goes with the kidney," that is, a normotensive recipient of a kidney genetically programmed for hypertension will develop hypertension. Intrarenal dopamine plays an important role in the pathogenesis of hypertension by regulating epithelial sodium transport. The candidate transport systems for L-DOPA, the source for dopamine, include the sodium-dependent systems B(0), B(0,+), and y(+)L, and the sodium-independent systems L (LAT1 and LAT2) and b(0,+). Renal LAT2 is overexpressed in the prehypertensive spontaneously hypertensive rat (SHR), which might contribute to enhanced L-DOPA uptake in the proximal tubule and increased dopamine production, as an attempt to overcome the defect in D1 receptor function. On the other hand, it has been recently reported that impaired arginine transport contributes to low renal nitric oxide bioavailability observed in the SHR renal medulla. Here we review the importance of renal amino acid transporters in the kidney and highlight pathophysiological changes in the expression and regulation of these transporters in essential hypertension. The study of the regulation of renal amino acid transporters may help to define the underlying mechanisms predisposing individuals to an increased risk for development of hypertension.
“…In fact, in immortalized SHR PTE cells, H 2 O 2 has been shown to stimulate Cl Ϫ /HCO 3 Ϫ exchanger activity via modification of thiol groups of intracellular and/or transmembrane proteins. The oxidized conformation of the exchanger enhanced the affinity for HCO 3 Ϫ in immortalized SHR PTE cells but not in WKY PTE cells (93). Cysteine residues of proteins are especially susceptible to oxidative stress and, given the important role that disulfides play in protein structure and stability, alterations of reactive cysteine thiol groups may change protein function and activity.…”
Several clinical and animal studies suggest that "blood pressure goes with the kidney," that is, a normotensive recipient of a kidney genetically programmed for hypertension will develop hypertension. Intrarenal dopamine plays an important role in the pathogenesis of hypertension by regulating epithelial sodium transport. The candidate transport systems for L-DOPA, the source for dopamine, include the sodium-dependent systems B(0), B(0,+), and y(+)L, and the sodium-independent systems L (LAT1 and LAT2) and b(0,+). Renal LAT2 is overexpressed in the prehypertensive spontaneously hypertensive rat (SHR), which might contribute to enhanced L-DOPA uptake in the proximal tubule and increased dopamine production, as an attempt to overcome the defect in D1 receptor function. On the other hand, it has been recently reported that impaired arginine transport contributes to low renal nitric oxide bioavailability observed in the SHR renal medulla. Here we review the importance of renal amino acid transporters in the kidney and highlight pathophysiological changes in the expression and regulation of these transporters in essential hypertension. The study of the regulation of renal amino acid transporters may help to define the underlying mechanisms predisposing individuals to an increased risk for development of hypertension.
“…It is widely accepted that oxidative stress contributes to tissue damage, thereby leading to pathological changes during the aging process. In both murine and human studies, researchers reported that aging was associated with increases in reactive oxygen species (ROS) generation and alterations in ROS removal ability [ 6 ]. Furthermore, renal oxidative stress is considered a major factor underlying the initiation of diabetic nephropathy [ 7 ].…”
The ability to maintain systemic metabolic homeostasis through various mechanisms represents a crucial strength of kidneys in the study of metabolic syndrome or aging. Moreover, age-associated kidney failure has been widely accepted. However, efforts to demonstrate aging-dependent renal metabolic rewiring have been limited.
In the present study, we investigated aging-related renal metabolic determinants by integrating metabolomic and transcriptomic data sets from kidneys of young (3 months,
n
= 7 and 3 for respectively) and old (24 months,
n
= 8 and 3 for respectively) naive C57BL/6 male mice. Metabolite profiling analysis was conducted, followed by data processing via network and pathway analyses, to identify differential metabolites. In the aged group, the levels of glutathione and oxidized glutathione were significantly increased, but the levels of gamma-glutamyl amino acids, amino acids combined with the gamma-glutamyl moiety from glutathione by membrane transpeptidases, and circulating glutathione levels were decreased. In transcriptomic analysis, differential expression of metabolic enzymes is consistent with the hypothesis of aging-dependent rewiring in renal glutathione metabolism; pathway and network analyses further revealed the increased expression of immune-related genes in the aged group.
Collectively, our integrative analysis results revealed that defective renal glutathione metabolism is a signature of renal aging. Therefore, we hypothesize that restraining renal glutathione metabolism might alleviate or delay age-associated renal metabolic deterioration, and aberrant activation of the renal immune system.
“…ROS can regulate ion transport 16–18,23,35–64 . Superoxide, produced by NADPH oxidase, enhances NaCl transport in the renal proximal tubule 16,17,39,44,45,59 , thick ascending limb of Henle 41,46,48 , and collecting duct 18,47,48 . The voltage-gated proton channel participates in the increased production of superoxide in the renal outer medulla of Dahl salt-sensitive rats 46 .…”
Section: Introductionmentioning
confidence: 99%
“…Increased ROS production is involved in the pathogenesis of many 1,5,8–17,22,23,25,28–44,48,57,60,62–64,68,71,72,86,89,92,104,138,140–154,162,163,173,189,197,210,214,218,219,221–233,236–244,246–252,262,263 270–273,278–280,295,305329–331 ,.…”
Hypertension is the most prevalent cause of cardiovascular disease and kidney failure but only about 50% of patients achieve adequate blood pressure control, in part, due to inter-individual genetic variations in the response to antihypertensive medication. Significant strides have been made toward the understanding of the role of reactive oxygen species (ROS) in the regulation of the cardiovascular system. However, the role of ROS in human hypertension is still unclear. Polymorphisms of some genes involved in the regulation of ROS production are associated with hypertension, suggesting their potential influence on blood pressure control and response to antihypertensive medication. This review provides an update on the genes associated with the regulation of ROS production in hypertension and discusses the controversies on the use of antioxidants in the treatment of hypertension, including the antioxidant effects of antihypertensive drugs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.